Joseph Capper becomes new CardioNet CEO
This article was originally published in Clinica
Executive Summary
Cardiac arrhythmia specialist CardioNet has employed Joseph Capper as its president and CEO. Mr Capper was previously president and CEO of diabetes management firm Home Diagnostics and medical supplies company CCS Medical. He also used to work for Bayer as national sales director of the group’s diabetic products division. Mr Capper replaces Randy Truman who will remain on CardioNet’s board of directors. Conshohocken, Pennsylvania-based CardioNet specialises in the diagnosis and monitoring of heart rhythm disorders with its mobile cardiac outpatient telemetry (MCOT).